Custom Recombinant Protein Production Services Market Size Is Anticipated To Reach US$ 7,517.2 Million at a CAGR of 11.2% By 2027 | Coherent Market Insights
Global Custom Recombinant Protein Production Services Market – Insights
Recombinant protein is a manipulated form of protein, which is encoded by genes. It finds application in research, biotechnology, and medicine and is used in the production of large quantities of proteins. Custom recombinant protein production has significant impact on healthcare and life sciences sectors.
The global custom recombinant protein production services market size was valued at US$ 3575.3 million in 2020, and is expected to exhibit a CAGR of 11.2% over the forecast period (2020 – 2027).
Figure 1. Global Custom Recombinant Protein Production Services Market Share (%) Analysis, By Expression System, 2020
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2737
Global Custom Recombinant Protein Production Services Market: Drivers
Increasing investment in R&D of custom recombinant proteins is expected to boost growth of the global custom recombinant protein production services market. For instance, Life Sciences Greenhouse of Central Pennsylvania offers early stage funding of up to US$ 1-2 million in the form of convertible debt or equity financing to viable life sciences companies, which have significant potential for commercial growth.
Moreover, increasing development in bioreactor systems has led to reduced production time for recombinant proteins, which is also expected to fuel growth of the global custom recombinant protein production services market over the forecast period. For instance, according to National Center for Biotechnology Information (NCBI), in 2014, around 65.6% of clinical scale manufacturers and 42% of commercial manufacturers adopted single-use bioreactors for improvement in their bioprocessing.
However, high cost of recombinant protein is expected to hamper growth of the market growth. The price of protein synthesis services ranges from US$ 3 to US$ 160 per amino acid depending upon the purity of the desired product. Moreover, the price of recombinant protein production services varies from US$ 500 to US$ 5000 per milligram depending upon the protein production expression systems, species of the proteins, and the family to which these recombinant proteins belong.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2737
Figure 2. Global Custom Recombinant Protein Production Services Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Global Custom Recombinant Protein Production Services Market: Regional Analysis
North America is expected to account for the largest market share in the global custom recombinant protein production services market over the forecast period. This is attributed to increasing R&D and launch of new products in the region. For instance, in 2014, Western Blot Service CRO, a division of Altogen Lab, launched automated WES protein analysis and protein expression services, providing a complete platform to conduct protein expression studies. Moreover, increasing M&A activities is also expected to boost growth of the market. For instance, in 2017, Eurofins Scientific acquired DiscoverX to improve research productivity and accelerate the discovery and development of new drugs and kinase products and services.
Global Custom Recombinant Protein Production Services Market: Competitive Landscape
Key players in the market are focused on adopting marketing strategies to enhance their market share. For instance, in 2014, Novoprotein participated in AAPS National Biotechnology Conference, which was dedicated to recent developments of protein recombinants, worldwide.
Major players operating in the global custom recombinant protein production services market include, Eurofins Pharma Discovery Services, GenScript Biotech Corporation, Applied Biological Materials Inc., Crown Bioscience, Inc., Abgent, OriGene Technologies, Inc., BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech, Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc., Proteos, Inc., Aldevron, and Sino Biological Inc.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/custom-recombinant-protein-production-services-market-to-surpass-us-67-billion-by-2026-1438
- Global Custom Recombinant Protein Production Services Market, By Expression System:
- Global Custom Recombinant Protein Production Services, By End User:
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire